StockData
LeonaBio, Inc. logo

LeonaBio, Inc. (LONA) stock

LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.65−0.11 (-3.99%)

Close on Nov 18, 2026Market cap $24.97MP/E –Yield –

LeonaBio cash

Cash and short-term investments held at the end of each period.

LeonaBio's cash was $51.07M at Jun 30, 2026. For fiscal 2025 it was $88.33M, up 72.3% from the year before. The highest annual figure on record is $253.76M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$88.33M+72.3%
FY2024Dec 31, 2024$51.28M-65.2%
FY2023Dec 31, 2023$147.42M-26.4%
FY2022Dec 31, 2022$200.34M-21.0%
FY2021Dec 31, 2021$253.76M+37.4%
FY2020Dec 31, 2020$184.68M+8882.6%
FY2019Dec 31, 2019$2.06M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$51.07M+71.2%
Q1 FY2026Mar 31, 2026$67.68M+84.6%
Q4 FY2025Dec 31, 2025$88.33M+72.3%
Q3 FY2025Sep 30, 2025$25.23M-63.4%
Q2 FY2025Jun 30, 2025$29.82M-67.5%
Q1 FY2025Mar 31, 2025$36.67M-70.0%
Q4 FY2024Dec 31, 2024$51.28M-65.2%
Q3 FY2024Sep 30, 2024$68.86M-60.2%
Q2 FY2024Jun 30, 2024$91.77M-50.7%
Q1 FY2024Mar 31, 2024$122.09M-34.4%
Q4 FY2023Dec 31, 2023$147.42M-26.4%
Q3 FY2023Sep 30, 2023$172.95M-21.7%
Q2 FY2023Jun 30, 2023$186.09M-26.3%
Q1 FY2023Mar 31, 2023$185.98M-29.4%
Q4 FY2022Dec 31, 2022$200.34M-21.0%
Q3 FY2022Sep 30, 2022$220.96M-6.3%
Q2 FY2022Jun 30, 2022$252.40M-11.4%
Q1 FY2022Mar 31, 2022$263.53M-13.4%
Q4 FY2021Dec 31, 2021$253.76M+37.4%
Q3 FY2021Sep 30, 2021$235.78M+4.2%
Q2 FY2021Jun 30, 2021$284.94M+13758.9%
Q1 FY2021Mar 31, 2021$304.19M–
Q4 FY2020Dec 31, 2020$184.68M–
Q3 FY2020Sep 30, 2020$226.27M–
Q4 FY2019Dec 31, 2019$2.06M–

More LeonaBio figures

See a number that looks wrong?